Lipopolysaccharide Binding Protein (LBP) (Middle Region) Peptid
LBP
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle LBP Produkte
- LBP (Lipopolysaccharide Binding Protein (LBP))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LBP antibody (Catalog #: ARP41545_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LBP (Lipopolysaccharide Binding Protein (LBP))
- Hintergrund
-
LBP is involved in the acute-phase immunologic response to gram-negative bacterial infections. Gram-negative bacteria contain a glycolipid, lipopolysaccharide (LPS), on their outer cell wall. Together with bactericidal permeability-increasing protein (BPI
Alias Symbols: MGC22233, BPIFD2
Protein Interaction Partner: APOA1,CAMP,CD14,CFHR1,RPS21,APOA1,CD14,CFHR1,IRF6
Protein Size: 481 - Molekulargewicht
- 51 kDa
- Gen-ID
- 3929
- NCBI Accession
- NM_004139, NP_004130
- UniProt
- P18428
-
Sie sind hier:
